neurotechnology

On Friday, Elon Musk announced that his brain-chip startup, Neuralink, is expected to commence its first human trial within this year. This news was shared at the VivaTech event in Paris, France, following a series of regulatory challenges and public concerns over the company’s animal testing...

Santa Monica, California-based startup TruBrain studied the thought patterns of successful people to develop a lineup of cognitive enhancement products. It brought in surgeons, artists, musicians and CEOs and examined how they think dynamically, manage distractions and their ability to cope with...

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk-led brain-machine interface startup Neuralink is recruiting a clinical trial director and a coordinator to realize plans for clinical trials in humans. What Happened: The billionaire entrepreneur's brain chip company has advertised the positions on its...

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk-led brain-machine interface startup said on Thursday it has secured $205 million in fresh funding — its largest so far. What Happened: The Series C-funding round — considered an early-stage investment — was led by tech-based venture capital...

Neuralink co-founder Max Hodak said he is no longer working with the neurotechnology startup he co-founded with Tesla Inc. (NASDAQ: TSLA) CEO Elon Musk and others. Hodak added he is “onward to new things.” What Happened: Hodak said on Twitter Saturday that he has not been working with...

Neuralink CEO Elon Musk said Thursday that the company’s first implant will allow someone with paralysis to use a smartphone with their mind faster than some using their thumbs. What Happened: Musk, who also leads Tesla Inc (NASDAQ: TSLA), made the revelation on Twitter in a series...

Benzinga recently had the chance to chat with Will Rosellini, a 37-year-old retired pro baseball player with six graduate degrees who now serves as the CEO of Nexeon MedSystems, a company that has developed a neurostimulation system for the treatment of neurological diseases. In previous articles,...

Benzinga recently had the chance to chat with Will Rosellini, a 37-year-old retired pro baseball player who now holds six graduate degrees and currently serves as the CEO of Nexeon MedSystems, a company that has developed a neurostimulation system for the treatment of neurological diseases. In the...

Will Rosellini is a 37-year-old, retired pro baseball player who now holds six graduate degrees, including an M.B.A., master's degrees in neurobiology and neurosciences, and a juris doctor degree. After a relatively short run with the Arizona Diamondbacks, Rosellini left baseball to focus on his...